Alabama Senate committee gives OK to medical marijuana

New Post Public Reply Private Reply Replies (1) Message Board
Health1 MattySimone #1900
Alabama Senate committee gives OK to medical marijuana bill
By Erin Edgemon

In a somewhat surprising move, a comprehensive medical marijuana bill passed in an Alabama Senate committee on Wednesday.

The Senate Judiciary Committee gave Sen. Bobby Singleton's bill a favorable report on a 4-3 vote after little debate. The Medical Marijuana Patient Safe Access Act can now be considered on the Senate floor.

Senate leadership could, however, refuse to put the bill on a calendar so it can be debated and voted on by the full body.

A standing room only crowd filled the committee room hoping to participate in a public hearing on the bill. That hearing, however, was taken off the committee agenda prior to the meeting.

Jeremy, one of those medical marijuana supporters who didn't want his last name used, said he is happy the committee passed the bill. He has considered moving out of state in order to purchase medical marijuana for treatment of his cerebral palsy.

He said traditional prescription drugs don't work for him.

"I have been more than 10 years sober waiting for something like this," Jeremy said.

Republicans have a super-majority in the Alabama Legislature, but the medical marijuana bill managed to pass today with a Democratic majority.

The favorable report was likely achieved because Republican senators Arthur Orr, Greg Reed and Tom Whatley didn't attend the meeting. Sen. Greg Albritton, a Republican, abstained.

Democratic senators Linda Coleman, Vivian Figures, Rodger Smitherman and Singleton voted in favor. Republican senators Cam Ward, who serves as committee chairman, Phil Williams and Larry Stutts voted against.

Singleton, D-Greensboro, said he lobbied hard to get the committee to approve the bill. He said he will continue to work hard to get lawmakers to put the bill on the calendar and heard on the Senate floor.

To do that, though, Singleton admitted he is considering substituting the current bill for a constitutional amendment, which would require a public election.

Singleton thinks Republican lawmakers will be more likely to pass the Legislation if it leaves the decision ultimately up to the voting public.

Ron Crumpton, a medical marijuana advocate who drafted the legislation, said "he is as happy as he can be" about today's approval.

"I don't think we would be anywhere on it if it wasn't for Sen. Singleton," he said.

This is the first time Singleton has carried the bill, and the first time members of the Senate have been able to consider a medical marijuana bill.

Previous legislation sponsored by Rep. Patricia Todd, D-Birmingham, failed to make it out of House Judicial Committee.

This year's legislation would allow for patients who suffer from 25-specific conditions to purchase a maximum of 10-ounces of medical marijuana per month from a dispensary.

Marijuana would be taxed at 2.5 percent; that sales tax revenue would go to sheriff or police departments to combat drug trafficking.

Certain patients would also be allowed to grow up to 16 plants of marijuana under the legislation.

Physicians would be required to perform a full examination on a patient before issuing a prescription card for medical marijuana, Singleton said. They would face penalties if they don't, he said.

Prescription cards would cost $100, and the state would recognize cards from other states.

"We have been demonizing marijuana for so long, but we are hearing that it can have medical benefits, Singleton told committee members.

"We have people in the audience in chronic pain who find this is one of the better treatments for them," he said later of medical marijuana.

Sen. Phil Williams, R-Gadsden, said he couldn't support a marijuana bill because he has seen the impact of drug abuse. Teenagers he has worked with used marijuana as a gateway drug.

Singleton said he understands the concerns that Williams and other lawmakers may have about the bill. He said medical marijuana is for the treatment of certain chronic conditions; there are safeguards in place to keep it out of the hands of children.

Updated at 3:14 pm. with additional information and comments from Sen. Singleton.
http://www.al.com/news/index.ssf/2015/04/alab...gives.html




Georgia has medical marijuana and next perhaps Alabama. This is awesome and almost unheard of in the conservative deep south. I am loving it...




Bots Inc. (BTZI) Stock Research Links

BTZI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

CeraVe Marks 20 Years of Groundbreaking Skincare Innovations

Updated Category News Views 259

CeraVe's Celebrated Journey in Skincare CeraVe is making waves as it marks an impressive milestone: 20 years of dedicated skincare science. Launching with the mission to nurture and restore skin health, the brand has garnered an extensive following of both customers and dermatology professionals worldwide. By focusing on skin barrier health and utilizing innovative...

Continue Reading
Exploring Novartis' Latest Innovations in Hematology and Oncology

Updated Category News Views 320

Novartis Pioneers Innovations in Hematology and Oncology Basel – Novartis has been making headlines with groundbreaking data presented at major medical meetings, including the esteemed American Society of Hematology (ASH) Annual Meeting and the San Antonio Breast Cancer Symposium (SABCS). This year, Novartis is showcasing over 70 abstracts with significant findings that...

Continue Reading
Sustainable Green Team Reveals Patents for Eco-Innovation

Updated Category News Views 189

Innovative Patents by Sustainable Green Team Sustainable Green Team, Ltd. (OTC: SGTM) is making significant strides in environmental responsibility by filing an impressive portfolio of 20 U.S. provisional patent applications. This initiative marks the unveiling of the SGTM 20-Patent Fortress™, consolidating the company's dedication to revolutionizing waste management...

Continue Reading
SSL's C2PA Game Changer: Authenticity or Just Hype?

Updated Category News Views 172

SSL just dropped a bombshell on the digital content authenticity scene. On February 18, 2026, they announced themselves as the first publicly trusted certificate authority to roll out production-ready C2PA-conformant certificates. But what’s behind all this noise? Desks are buzzing about whether this marks a real breakthrough against deepfakes and misinformation or if...

Continue Reading
MiMedia's Innovations at Mobile World Congress Excite Investors

Updated Category News Views 95

MiMedia Partners with Orbic at Mobile World Congress MiMedia Holdings Ltd. is excited to announce its collaboration with Orbic, a prominent US OEM, to develop and market the new line of rugged devices under the Caterpillar brand. This partnership was highlighted during the recently attended Mobile World Congress conference, where innovative trends within the tech industry...

Continue Reading